Literature DB >> 25687758

PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60.

Wai-Hang Leung1, Queenie P Vong1, Wenwei Lin2, David Bouck2, Susanne Wendt1, Erin Sullivan1, Ying Li1, Rafijul Bari1, Taosheng Chen2, Wing Leung3.   

Abstract

Many malignant cells release the NKG2D ligand ULBP2 from their cell surface to evade immunosurveillance by NK cells and CD8 T cells. Although the shedding mechanism remains unclear, various inhibitors of matrix metalloproteinases have been shown to efficiently block the release of soluble ULBP2. The clinical use of these inhibitors, however, is limited because of adverse side effects. Using high-throughput screening technique, we identified a specific inhibitor of phosphatase of regenerating liver 3 (PRL-3) that could reduce the level of soluble ULBP2 in the culture supernatant of various cancer cell lines. Inhibition or gene knockdown of PRL-3 did not reduce ULBP2 shedding, but rather suppressed posttranslational maturation of ULBP2, resulting in intracellular retention of immature ULBP2. We then found that ULBP2 was constitutively associated with heat shock protein HSP60. Complete maturation of ULBP2 required tyrosine phosphorylation of HSP60 which was mediated by PRL-3.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25687758      PMCID: PMC4355089          DOI: 10.4049/jimmunol.1400817

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Immunodetection of glycophosphatidylinositol-anchored proteins following treatment with phospholipase C.

Authors:  Koren A Nishina; Surachai Supattapone
Journal:  Anal Biochem       Date:  2007-01-26       Impact factor: 3.365

2.  TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.

Authors:  Günter Eisele; Jörg Wischhusen; Michel Mittelbronn; Richard Meyermann; Inja Waldhauer; Alexander Steinle; Michael Weller; Manuel A Friese
Journal:  Brain       Date:  2006-08-03       Impact factor: 13.501

3.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Authors:  Stephan Gasser; Sandra Orsulic; Eric J Brown; David H Raulet
Journal:  Nature       Date:  2005-07-03       Impact factor: 49.962

4.  PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.

Authors:  Fubo Liang; Jiao Liang; Wei-Qing Wang; Jin-Peng Sun; Eshwar Udho; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

5.  Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation.

Authors:  Meltem Sariahmetoglu; Bryan D Crawford; Hernando Leon; Jolanta Sawicka; Laiji Li; Barbara J Ballermann; Charles Holmes; Luc G Berthiaume; Andrew Holt; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2007-04-13       Impact factor: 5.191

6.  ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.

Authors:  Alessandra Soriani; Alessandra Zingoni; Cristina Cerboni; Maria Luisa Iannitto; Maria Rosaria Ricciardi; Valentina Di Gialleonardo; Marco Cippitelli; Cinzia Fionda; Maria Teresa Petrucci; Anna Guarini; Robin Foà; Angela Santoni
Journal:  Blood       Date:  2008-12-19       Impact factor: 22.113

7.  Detection of glycophospholipid anchors on proteins.

Authors:  T L Doering; P T Englund; G W Hart
Journal:  Curr Protoc Protein Sci       Date:  2001-05

8.  Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Authors:  Klarisa Rikova; Ailan Guo; Qingfu Zeng; Anthony Possemato; Jian Yu; Herbert Haack; Julie Nardone; Kimberly Lee; Cynthia Reeves; Yu Li; Yerong Hu; Zhiping Tan; Matthew Stokes; Laura Sullivan; Jeffrey Mitchell; Randy Wetzel; Joan Macneill; Jian Min Ren; Jin Yuan; Corey E Bakalarski; Judit Villen; Jon M Kornhauser; Bradley Smith; Daiqiang Li; Xinmin Zhou; Steven P Gygi; Ting-Lei Gu; Roberto D Polakiewicz; John Rush; Michael J Comb
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 9.  The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.

Authors:  Jerry W Skiles; Nina C Gonnella; Arco Y Jeng
Journal:  Curr Med Chem       Date:  2004-11       Impact factor: 4.530

Review 10.  Promiscuity and the single receptor: NKG2D.

Authors:  Robert A Eagle; John Trowsdale
Journal:  Nat Rev Immunol       Date:  2007-08-03       Impact factor: 53.106

View more
  5 in total

1.  PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

Authors:  Min Thura; Abdul Qader Omer Al-Aidaroos; Wei Peng Yong; Koji Kono; Abhishek Gupta; You Bin Lin; Kousaku Mimura; Jean Paul Thiery; Boon Cher Goh; Patrick Tan; Ross Soo; Cheng William Hong; Lingzhi Wang; Suling Joyce Lin; Elya Chen; Sun Young Rha; Hyun Cheol Chung; Jie Li; Sayantani Nandi; Hiu Fung Yuen; Shu-Dong Zhang; Yeoh Khay Guan; Jimmy So; Qi Zeng
Journal:  JCI Insight       Date:  2016-06-16

Review 2.  Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.

Authors:  Yangyang Wang; Xinhui Wang; Cristina R Ferrone; Joseph H Schwab; Soldano Ferrone
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603

3.  HSP60 possesses a GTPase activity and mediates protein folding with HSP10.

Authors:  Tomoya Okamoto; Hiroshi Yamamoto; Ikuru Kudo; Kazuya Matsumoto; Masafumi Odaka; Ewa Grave; Hideaki Itoh
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

4.  Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.

Authors:  Zhenzhen Gao; Peng Fu; Zhengyi Yu; Fuxi Zhen; Yanhong Gu
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

5.  Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone.

Authors:  Xiang Yin; Liangshu Feng; Di Ma; Ping Yin; Xinyu Wang; Shuai Hou; Yulei Hao; Jingdian Zhang; Meiying Xin; Jiachun Feng
Journal:  J Neuroinflammation       Date:  2018-03-27       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.